[ad_1]
The Ministry of Health and Population warned against the circulation of two adulterated drugs for the treatment of tumors and cancer in the local market, one of which provided by the General Authority of Health insurance to fight against "bad cancer".
The Central Department of Pharmaceutical Affairs has issued a circular No. 28 for the year 2019 on "commercial fraud" for both dots. It consists of controlling and monitoring what one can find on the local market and in government units of these drugs after taking all stored procedures with "government units".
Dr. Rasha Ziadeh, head of the central administration of pharmaceutical affairs at "Health", spoke to ministry officials in the health directorates of the various governorates responsible for controlling and monitoring these drugs, saying that these operations were deceived on the Egyptian market. The pharmacokinetics of non-compliance of two batches of the two products in question. The first of these articles is Prigita 240 milligrams, bearing the numbers H022B03, H0304B04 and Avestin, running B7254B01.
According to the circular, ministry agents in the provinces were required to hand over the company representative to the winners after making the necessary commitment not to remove the seals except in the presence of one of the pharmacist's inspectors , while providing "pharmaceutical companies" with controlled quantities. .
She also sent the chief of pharmaceutical affairs, this publication to the company producing the drug and the owner of the preparation, as well as drug distribution companies to freeze the balances of these operations and to return to pharmacists the products sold or provided to pharmacies in the company's stores and to inform the Department of Health.
[ad_2]
Source link
